October 17, 2011
Dr Jörg Steiner and his colleagues at Texas A&M University College of Veterinary Medicine are currently enrolling dogs with chronic pancreatitis and diabetes mellitus for a treatment trial with cyclosporine. The aim of this study is to evaluate cyclosporine as a novel therapy for dogs with difficult to regulate diabetes mellitus and chronic pancreatitis. There is some evidence in the human literature that chronic pancreatitis may have an underlying immune-mediated etiology and anecdotally, cyclosporine has resulted in improved diabetic control in dogs with chronic pancreatitis as a cause of insulin resistance. Qualifying cases will receive Atopica free of charge for the trial period of six weeks. For more information please contact Dr Heather Kvitko-White at email@example.com.